Skip to content
★ Sign in to follow
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd logo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Stock: price and insider trades · China

三生国健

CN·Mcap CN¥30.7BHealth Care

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd: what insiders have been doing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd has a thin disclosure history in our data (latest filing: 7 December 2022). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€20,086
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 383 of 26,912 companies
86.0
score / 100
Value
75
Quality
97
FCF yld9.1%
Earn yld9.5%
EV/EBITDA8.9x
ROE44%
Gross mgn92%
Net mgn69%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥34.22
Analyst consensus
1 analysts
·
CN¥60.94Target CN¥60.94(+78%)CN¥60.94
Income statement
RevenueCN¥4.2B
Gross profitCN¥3.9B92% margin
EBITDACN¥3.4B82% margin
Net incomeCN¥2.9B69.6% margin
Valuation
PER (trailing)10.1x
PER (forward)41.2x
P/Book3.6x
Beta0.33
Balance sheet & cash
Market capCN¥30.7B
Total debtCN¥50M
Free Cash FlowCN¥2.8B
Profitability & ownership
ROE43.5%
ROA27.8%
% insiders84.4%
% institutions5.0%
Last declaration on 7 December 2022
Declarations1 total
  • ▼
    核心技术人员Executives
    147,288 CNY10SSE
    10,200 shares100.0% of flowA股XSHGSSE:173000006112585300

1 of 1 declaration

About Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

三生国健 is a company focused on the health and pharmaceutical sector. It is listed on the Shanghai Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations